Non-Hodgkin Lymphoma

Diverse lymph-node cancers — focal residual disease can be ablated locally.

Cancer

Non-Hodgkin Lymphoma

What is this cancer?

Non-Hodgkin lymphomas are a large family of B-cell, T-cell and NK-cell neoplasms with very different tempos, from slow-growing to highly aggressive. Nodes may enlarge in one region or throughout the body.

Warning signs

  • Painless enlarged nodes in the neck, armpit or groin
  • Fever, drenching night sweats and weight loss
  • Abdominal fullness, chest discomfort or persistent fatigue

Diagnosis & staging

Excision or core biopsy with immunophenotyping establishes the subtype; PET-CT and bone-marrow assessment stage disease, while lumbar puncture is reserved for CNS-risk lymphomas.

Treatment at St. Stamford

Chemoimmunotherapy and targeted agents lead treatment. Our interventional contribution includes safe biopsy of deep nodes, drainage or stenting of obstructions, ablation of a PET-positive residual or oligorecurrent mass, and embolization of rare vascular bulky disease.

Why minimally invasive care

Image-guided ablation and embolization treat the tumour through millimetre-sized punctures, sparing healthy tissue and shortening hospital stay — often an option when surgery, age or prior treatment make open surgery risky.

Every pathway at St. Stamford is planned by a multidisciplinary team — interventional radiologists, medical oncologists and imaging specialists review your scans together. Send your reports before you travel and receive a written pathway in English.

Still have questions?

Reach our care team for personalized guidance on diagnosis, treatment, and insurance.

Request a Consultation
← Back to Cancer